Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)

The summary for the Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity, related to 1) immune system development and function, 2) immunity to vaccines or natural infections, or 3) allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation.

Federal Grant Title:	Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-24-112
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 7th, 2027
Original Application Deadline:	January 7th, 2027
Posted Date:	January 25th, 2024
Creation Date:	January 25th, 2024
Archive Date:	February 12th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 25th, 2024

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-24-112.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed); • Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed); • Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (...; • Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) (P01 Clinical T...; • Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CE...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed); • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Sch...; • Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed); • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco...